INMNasdaq Canada
Market cap
$4.122 M
$1.47 +2.80%
Close of 7 Aug 2026
Revenue
$4.94M
#3302 by revenue
Earnings
-$8.16M
Loss-making
Shares outstanding
3,314,063
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for InMed Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.